•
Mar 31, 2022

Natera Q1 2022 Earnings Report

Reported first quarter results with revenue increase and raised 2022 revenue forecast.

Key Takeaways

Natera reported a 27.5% increase in total revenues to $194.1 million for the first quarter of 2022, driven by a 57.8% increase in product revenues. The company processed 489,300 tests and reported a net loss of $138.6 million, or ($1.45) per diluted share. They are raising their 2022 revenue forecast by $20 million.

Total revenues increased by 27.5% to $194.1 million compared to Q1 2021.

Product revenues increased by 57.8% to $190.0 million compared to Q1 2021.

Approximately 489,300 tests were processed in Q1 2022.

Net loss for Q1 2022 was $138.6 million, or ($1.45) per diluted share.

Total Revenue
$194M
Previous year: $152M
+27.5%
EPS
-$1.45
Previous year: -$0.74
+95.9%
Tests Processed
489.3K
Previous year: 348.2K
+40.5%
Tests Accessioned
473.2K
Previous year: 333.4K
+41.9%
Total Tests Reported
456.1K
Previous year: 313.8K
+45.3%
Gross Profit
$90.9M
Previous year: $85.5M
+6.3%
Cash and Equivalents
$752M
Previous year: $654M
+15.1%
Free Cash Flow
-$153M
Previous year: -$85.1M
+79.9%
Total Assets
$1.14B
Previous year: $894M
+28.1%

Natera

Natera

Forward Guidance

Natera anticipates 2022 total revenue of $790 million to $810 million; 2022 gross margin to be approximately 46% to 48% of revenues; selling, general and administrative costs to be approximately $560 million to $590 million; research and development costs to be $340 million to $360 million, and net cash consumption to be $370 million to $400 million.